研究单位：[1]Capital Medical University[2]Xuanwu Hospital,Capital Medical University Beijing,Beijing,China,100053[3]First Affiliated Hospital of Hainan Medical University Haikou,Hainan,China,570102[4]Taoyuan People's Hospital Changde,Hunan,China[5]Shengli Oilfield Center Hospital Dongying,Shandong,China,257034
研究目的：
This is a single-arm, open-labeled and phase II futility study. Application of Remote ischemic conditioning (RIC) as an adjunctive therapy to medication were involved in the study. The study is to test whether RIC is effective in preventing ischemic evens after a minor ischemic stroke/transient ischemic attack within 3 months and to explore the safety and compliance of chronic RIC. Medication strategy is based on physician's best judgement.
